GM-CSF has been shown to enhance the ability of influenza DNA vaccines to induce antibody responses and protection in mice [37], [38], but not in the context of influenza DNA vaccines in either the clinic or a relevant large animal preclinical model. Here, CSF2 is linked to influenza.